zeon

Rubber-related Companies Recognized for Excellent Health Management

The Excellent Corporation for Health Management certification system recognizes corporations, including large enterprises and small-to-medium businesses, that practice exemplary health management. It is divided into the Large-Scale Corporation Category and the Small-to-Medium-Scale Corporation Category, with top performers in the former category earning the additional White 500 designation. Moreover, the Health and Productivity Stock Selection is a program by the Ministry...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Zeon Establishes Chinese JV for Lithium-ion Battery Anode Binders

Zeon Trading (Shanghai), a wholly owned subsidiary of Zeon Corporation, has agreed with Zhuhai Chenyu New Materials Technology (Chenyu), an affiliate of Shanghai Energy New Materials Technology (Semcorp), to establish Shanghai Chenon New Materials Technology, a joint venture to sell binders for negative electrodes used in lithium ion batteries. The investment ratio is 51% by Chenyu and 49% by Zeon...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Yokohama Rubber and Zeon to Construct Bench Facility for Sustainable Butadiene

Yokohama Rubber and Zeon will construct a bench facility at Zeon’s Tokuyama Plant in Shunan City to demonstrate a highly efficient technology for generating butadiene from ethanol derived from plant materials. The facility will begin operating in 2026, and will collect various data for securing butadiene and for mass production. This initiative is one of two R&D themes selected in...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Zeon Invests in Company Developing Cancer Therapy

Zeon has invested in Optieum Biotechnologies, a developer of innovative CAR T cells. Optieum is aiming to commercialize the world’s first innovative CAR T cell therapy for solid tumors. One of the cancer therapies classified as gene therapy, the new therapy is based on the Eumbody System technology developed at Ehime University, which can efficiently produce chimeric antigen receptors (CAR)...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Special Feature on Current Status of Synthetic Rubber: Zeon

In the first half (April-September) of fiscal 2024, Zeon’s elastomer materials division posted sales of 120.65 billion yen ($764.68 million), up 15.2% year-on-year, and operating profit of 6.01 billion yen, up 65.0%. Synthetic rubber shipments were up 1%. In general-purpose synthetic rubber, sales of solution-polymerized styrene-butadiene rubber (S-SBR) were strong as demand recovered. Meanwhile, emulsion-polymerized styrene-butadiene rubber (E-SBR) and butadiene...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading

Zeon Posts First Half Results, Elastomer Materials Business Increases Sales and Profit

Zeon reported a 15.0% year-on-year increase in net sales to 213.35 billion yen ($1.38 billion), a 77.6% rise in operating income to 16.80 billion yen, a 42.6% increase in ordinary income to 18.59 billion yen, and an 18.7% rise in net income to 12.30 billion yen in the first half (April-September) of the fiscal year ending March 2025. In the...

Please subscribe to read the full story.Subscribe
Already a member? Log in here
Continue Reading